OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. The company is headquartered in Waltham, Massachusetts and currently employs 104 full-time employees. The company went IPO on 2005-05-18. The Company’s platform combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. Its DAAP generates dynamic audiences with predictive analytics via machine learning methods. MNT creates consumer audiences using a privacy-first process. Its principal solutions include Audience Development: DAAP and MNT, Audience Profiling: Profiler, Audience Activation and Media Execution, Pharmacy Alerts, and Financial Messaging. Its Financial Messaging provides prescribers visibility to branded copay offers for patients directly within their electronic health record (EHR) systems and electronic prescribing (ERx) platforms. Its platform consists of a unified data intelligence technology stack, multiple cloud-based data warehouses, and in-house applications and application programming interface layers.
Mr. Stephen Silvestro 2019 'den beri şirketle birlikte olan OptimizeRx Corp 'in President 'ıdır.
OPRX hissesinin fiyat performansı nasıl?
OPRX 'in mevcut fiyatı $5.85 'dir, son işlem günde 7.72% azalmış etti.
OptimizeRx Corp için ana iş temaları veya sektörler nelerdir?
OptimizeRx Corp Health Care endüstrisine ait ve sektör Health Care 'dir
OptimizeRx Corp 'in piyasa değerlemesi nedir?
OptimizeRx Corp 'in mevcut piyasa değerlemesi $109.7M 'dir
OptimizeRx Corp al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 8 analist OptimizeRx Corp için analist derecelendirmeleri gerçekleştirdi, bunlar 4 güçlü al, 7 al, 2 tut, 0 sat ve 4 güçlü sat içermektedir